Iron in PDB 4uhx: Human Aldehyde Oxidase in Complex with Phthalazine and Thioridazine
Enzymatic activity of Human Aldehyde Oxidase in Complex with Phthalazine and Thioridazine
All present enzymatic activity of Human Aldehyde Oxidase in Complex with Phthalazine and Thioridazine:
1.2.3.1;
Protein crystallography data
The structure of Human Aldehyde Oxidase in Complex with Phthalazine and Thioridazine, PDB code: 4uhx
was solved by
C.Coelho,
M.J.Romao,
T.Santos-Silva,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
105.17 /
2.70
|
Space group
|
P 42 21 2
|
Cell size a, b, c (Å), α, β, γ (°)
|
148.732,
148.732,
132.808,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
19.526 /
24.408
|
Other elements in 4uhx:
The structure of Human Aldehyde Oxidase in Complex with Phthalazine and Thioridazine also contains other interesting chemical elements:
Iron Binding Sites:
The binding sites of Iron atom in the Human Aldehyde Oxidase in Complex with Phthalazine and Thioridazine
(pdb code 4uhx). This binding sites where shown within
5.0 Angstroms radius around Iron atom.
In total 4 binding sites of Iron where determined in the
Human Aldehyde Oxidase in Complex with Phthalazine and Thioridazine, PDB code: 4uhx:
Jump to Iron binding site number:
1;
2;
3;
4;
Iron binding site 1 out
of 4 in 4uhx
Go back to
Iron Binding Sites List in 4uhx
Iron binding site 1 out
of 4 in the Human Aldehyde Oxidase in Complex with Phthalazine and Thioridazine
 Mono view
 Stereo pair view
|
A full contact list of Iron with other atoms in the Fe binding
site number 1 of Human Aldehyde Oxidase in Complex with Phthalazine and Thioridazine within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Fe3001
b:52.7
occ:1.00
|
FE1
|
A:FES3001
|
0.0
|
52.7
|
1.0
|
SG
|
A:CYS117
|
2.1
|
56.8
|
1.0
|
S2
|
A:FES3001
|
2.2
|
47.5
|
1.0
|
S1
|
A:FES3001
|
2.2
|
49.9
|
1.0
|
SG
|
A:CYS149
|
2.4
|
51.1
|
1.0
|
FE2
|
A:FES3001
|
3.0
|
49.3
|
1.0
|
CB
|
A:CYS117
|
3.3
|
55.4
|
1.0
|
CB
|
A:CYS149
|
3.5
|
52.5
|
1.0
|
CA
|
A:CYS149
|
4.0
|
53.1
|
1.0
|
N
|
A:CYS117
|
4.1
|
54.2
|
1.0
|
CA
|
A:CYS117
|
4.3
|
54.8
|
1.0
|
N
|
A:ARG150
|
4.4
|
52.4
|
1.0
|
CG2
|
A:THR152
|
4.5
|
58.3
|
1.0
|
C
|
A:CYS149
|
4.6
|
53.2
|
1.0
|
N
|
A:CYS151
|
4.6
|
53.6
|
1.0
|
CB
|
A:CYS151
|
4.7
|
54.0
|
1.0
|
SG
|
A:CYS114
|
4.8
|
59.0
|
1.0
|
C
|
A:CYS117
|
4.8
|
55.3
|
1.0
|
N
|
A:GLY115
|
4.9
|
56.3
|
1.0
|
SG
|
A:CYS151
|
4.9
|
54.3
|
1.0
|
O
|
A:LEU148
|
5.0
|
55.6
|
1.0
|
|
Iron binding site 2 out
of 4 in 4uhx
Go back to
Iron Binding Sites List in 4uhx
Iron binding site 2 out
of 4 in the Human Aldehyde Oxidase in Complex with Phthalazine and Thioridazine
 Mono view
 Stereo pair view
|
A full contact list of Iron with other atoms in the Fe binding
site number 2 of Human Aldehyde Oxidase in Complex with Phthalazine and Thioridazine within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Fe3001
b:49.3
occ:1.00
|
FE2
|
A:FES3001
|
0.0
|
49.3
|
1.0
|
S2
|
A:FES3001
|
2.2
|
47.5
|
1.0
|
S1
|
A:FES3001
|
2.2
|
49.9
|
1.0
|
SG
|
A:CYS114
|
2.3
|
59.0
|
1.0
|
SG
|
A:CYS151
|
2.5
|
54.3
|
1.0
|
FE1
|
A:FES3001
|
3.0
|
52.7
|
1.0
|
CB
|
A:CYS114
|
3.1
|
57.3
|
1.0
|
CB
|
A:CYS151
|
3.3
|
54.0
|
1.0
|
N
|
A:CYS114
|
3.5
|
57.1
|
1.0
|
CA
|
A:CYS114
|
3.8
|
56.7
|
1.0
|
N
|
A:GLY115
|
3.9
|
56.3
|
1.0
|
N
|
A:CYS151
|
4.1
|
53.6
|
1.0
|
C
|
A:CYS114
|
4.2
|
55.7
|
1.0
|
CA
|
A:CYS151
|
4.4
|
54.2
|
1.0
|
N
|
A:PHE116
|
4.5
|
52.8
|
1.0
|
SG
|
A:CYS149
|
4.5
|
51.1
|
1.0
|
C
|
A:GLN113
|
4.7
|
57.3
|
1.0
|
N
|
A:ARG150
|
4.8
|
52.4
|
1.0
|
CB
|
A:GLN113
|
4.9
|
57.3
|
1.0
|
SG
|
A:CYS117
|
4.9
|
56.8
|
1.0
|
CA
|
A:GLY115
|
4.9
|
54.9
|
1.0
|
C
|
A:ARG150
|
5.0
|
53.2
|
1.0
|
|
Iron binding site 3 out
of 4 in 4uhx
Go back to
Iron Binding Sites List in 4uhx
Iron binding site 3 out
of 4 in the Human Aldehyde Oxidase in Complex with Phthalazine and Thioridazine
 Mono view
 Stereo pair view
|
A full contact list of Iron with other atoms in the Fe binding
site number 3 of Human Aldehyde Oxidase in Complex with Phthalazine and Thioridazine within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Fe3002
b:89.3
occ:1.00
|
FE1
|
A:FES3002
|
0.0
|
89.3
|
1.0
|
SG
|
A:CYS49
|
2.2
|
62.9
|
1.0
|
S1
|
A:FES3002
|
2.2
|
90.6
|
1.0
|
S2
|
A:FES3002
|
2.2
|
92.7
|
1.0
|
FE2
|
A:FES3002
|
3.1
|
90.6
|
1.0
|
N
|
A:CYS44
|
3.2
|
67.7
|
1.0
|
SG
|
A:CYS44
|
3.3
|
71.9
|
1.0
|
CB
|
A:CYS49
|
3.5
|
59.6
|
1.0
|
N
|
A:CYS49
|
3.6
|
61.4
|
1.0
|
CB
|
A:CYS44
|
3.8
|
70.1
|
1.0
|
N
|
A:GLY45
|
3.9
|
69.5
|
1.0
|
N
|
A:GLY50
|
3.9
|
56.1
|
1.0
|
CA
|
A:CYS44
|
3.9
|
69.4
|
1.0
|
CA
|
A:CYS49
|
3.9
|
59.4
|
1.0
|
C
|
A:GLY43
|
4.1
|
65.7
|
1.0
|
CA
|
A:GLY43
|
4.1
|
63.0
|
1.0
|
N
|
A:ALA51
|
4.2
|
54.0
|
1.0
|
N
|
A:GLY43
|
4.2
|
60.1
|
1.0
|
C
|
A:CYS49
|
4.2
|
57.2
|
1.0
|
N
|
A:GLY48
|
4.3
|
66.4
|
1.0
|
C
|
A:CYS44
|
4.3
|
69.6
|
1.0
|
CB
|
A:ALA51
|
4.6
|
52.8
|
1.0
|
N
|
A:GLY47
|
4.7
|
69.4
|
1.0
|
C
|
A:GLY48
|
4.7
|
63.4
|
1.0
|
SG
|
A:CYS52
|
4.7
|
57.3
|
1.0
|
CA
|
A:GLY50
|
4.8
|
55.3
|
1.0
|
C
|
A:GLY47
|
4.9
|
68.7
|
1.0
|
CA
|
A:ALA51
|
4.9
|
53.6
|
1.0
|
N
|
A:CYS52
|
5.0
|
54.1
|
1.0
|
CA
|
A:GLY47
|
5.0
|
69.2
|
1.0
|
CA
|
A:GLY45
|
5.0
|
70.3
|
1.0
|
C
|
A:GLY50
|
5.0
|
54.8
|
1.0
|
CA
|
A:GLY48
|
5.0
|
64.8
|
1.0
|
|
Iron binding site 4 out
of 4 in 4uhx
Go back to
Iron Binding Sites List in 4uhx
Iron binding site 4 out
of 4 in the Human Aldehyde Oxidase in Complex with Phthalazine and Thioridazine
 Mono view
 Stereo pair view
|
A full contact list of Iron with other atoms in the Fe binding
site number 4 of Human Aldehyde Oxidase in Complex with Phthalazine and Thioridazine within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Fe3002
b:90.6
occ:1.00
|
FE2
|
A:FES3002
|
0.0
|
90.6
|
1.0
|
SG
|
A:CYS52
|
2.2
|
57.3
|
1.0
|
S2
|
A:FES3002
|
2.2
|
92.7
|
1.0
|
S1
|
A:FES3002
|
2.2
|
90.6
|
1.0
|
SG
|
A:CYS74
|
2.6
|
57.5
|
1.0
|
FE1
|
A:FES3002
|
3.1
|
89.3
|
1.0
|
CB
|
A:CYS74
|
3.3
|
56.7
|
1.0
|
CB
|
A:CYS52
|
3.5
|
54.8
|
1.0
|
N
|
A:GLY47
|
4.1
|
69.4
|
1.0
|
CB
|
A:ASN72
|
4.2
|
57.6
|
1.0
|
CA
|
A:GLY47
|
4.3
|
69.2
|
1.0
|
N
|
A:GLY45
|
4.3
|
69.5
|
1.0
|
N
|
A:CYS52
|
4.3
|
54.1
|
1.0
|
N
|
A:CYS74
|
4.3
|
56.3
|
1.0
|
CA
|
A:CYS74
|
4.4
|
56.9
|
1.0
|
CA
|
A:CYS52
|
4.5
|
54.1
|
1.0
|
CA
|
A:GLY45
|
4.5
|
70.3
|
1.0
|
CG
|
A:ASN72
|
4.6
|
59.1
|
1.0
|
ND2
|
A:ASN72
|
4.6
|
58.6
|
1.0
|
N
|
A:GLY46
|
4.8
|
72.0
|
1.0
|
C
|
A:GLY45
|
5.0
|
71.8
|
1.0
|
|
Reference:
C.Coelho,
A.Foti,
T.Hartmann,
T.Santos-Silva,
S.Leimkuhler,
M.J.Romao.
Structural Insights Into Xenobiotic and Inhibitor Binding to Human Aldehyde Oxidase Nat.Chem.Biol. V. 11 779 2015.
ISSN: ISSN 1552-4450
PubMed: 26322824
DOI: 10.1038/NCHEMBIO.1895
Page generated: Mon Aug 5 13:28:45 2024
|